Industrial Investor Pays $24M for Teva's Irvine Campus - Orange County Business Journal
NuPathe acquired by Teva for $144M - Technical.ly
Earnings Preview: It's a mixed bag for Teva Pharma in Q3 | AlphaStreet
Teva Pharmaceutical: Investment Opportunity During Fed Rate Hike (NYSE:TEVA) | Seeking Alpha
Why the Teva Pharmaceuticals Stock Rebound May Be Real | InvestorPlace
Teva ponies up $420M to settle with investors who said company hid price-fixing scheme | Fierce Pharma
Suffering from missteps, drugmaker Teva struggles to heal own ills | The Times of Israel
Jewish Values Investors JLens Target Israeli Company
Teva Pharmaceuticals - Wikipedia
Teva Pharmaceuticals has acquired success with Actavis Generics | World Finance
Teva Pharmaceutical Industries Adds US$389m To Market Cap, But Investors Still Down 47% From Five Years Ago - Simply Wall St News
The Teva-Allergan deal shows why pharma mergers are booming | Fortune
Teva Pharmaceutical Stock Could Double | Barron's
Teva Reports Second Quarter 2022 Financial Results | Business Wire
Five Considerations After Teva Pharmaceuticals' Q3 Report (NYSE:TEVA) | Seeking Alpha
Teva Stock Skyrockets After Inking North Of $4 Billion In Opioid Settlements | Investor's Business Daily
Investors sue Teva over $41B Actavis deal - Drug Delivery Business
Analysis: Teva Pharmaceuticals is bogged down by legal issues, fails to kick-start growth | Ctech
Teva Pharmaceuticals Portfolio Investments, Teva Pharmaceuticals Funds, Teva Pharmaceuticals Exits
Teva completes $40b purchase of Allergan generics arm | The Times of Israel
Buy Teva Pharmaceuticals amid positive news, Bernstein says
TEVA Pharmaceuticals sells Forest facility to private investor | WSET
6 Reasons I've Been Aggressively Buying Teva Pharmaceutical Industries | The Motley Fool
Teva Stock Price Today | NYSE TEVA Live Ticker - Investing.com
Teva Seeks New CFO as It Faces High Debt Levels, Opioid Litigation - WSJ
